Sponsored by:

Business in the Burbs

Movers, shakers and newsmakers

Progenics to move ahead with HIV treatment


Progenics Pharmaceuticals Inc., a Tarrytown-based biotech company, said that the company plans further development of an injectable treatment for HIV infection known as PRO 140. Progenics said that the decision follows positive results from a study of the treatment and positive comments from treatment advocates and people living with HIV. Progenics added that the study showed that PRO 140 perfomed better than a placebo and was well tolerated by patients.

This entry was posted on Tuesday, February 10th, 2009 at 1:59 pm by Jay Loomis. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Biopharmaceutical



About this blog
Business in the Burbs is our online news blog about businesses based or operating in the Lower Hudson Valley. Visitors here will also find items of interest to consumers in the region. Most contributions are from business reporters and editors covering Westchester, Rockland and Putnam counties.


Get blog updates via email:

About the Authors


Other recent entries


Monthly Archives